BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26854258)

  • 1. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
    La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
    Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
    Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
    World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
    Stine JG; Wang J; Shah PM; Argo CK; Intagliata N; Uflacker A; Caldwell SH; Northup PG
    Liver Int; 2018 Jan; 38(1):94-101. PubMed ID: 28632958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein thrombosis and survival in patients with cirrhosis.
    Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
    Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
    Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
    J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Era of liver transplantation: combined anatomic splenectomy and anticoagulant therapy in prevention of portal vein thrombosis after splenectomy.
    Hongwei C; Zhang L; Maoping L; Yong Z; Chengyou D; Dewei L
    Hepatogastroenterology; 2015; 62(138):405-9. PubMed ID: 25916072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
    Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z; Zhao H; Wang X; Zhang H; Jiang M; Tsauo J; Luo X; Yang L; Li X
    Abdom Imaging; 2015 Aug; 40(6):1813-20. PubMed ID: 25504374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization].
    Zhang Y; Wen TF; Chen ZY; Yan LN; Liang GL; Li G; Zhang XH; Ran S; Liao ZX
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):825-8. PubMed ID: 19961011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
    Sun L; Zhou H; Gu L; Jiang C; Liu Y; Xu Q
    Int J Surg; 2015 Apr; 16(Pt A):31-35. PubMed ID: 25701619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.